Neratinib induces estrogen receptor function and sensitizes HER2-mutant breast cancer to anti-endocrine therapy Meeting Abstract
| Authors: | Scaltriti, M.; Carmona, F. J.; Toska, E.; Cocco, E.; Hyman, D.; Cutler, R.; Avogadri-Connors, F.; Wick, M. J.; Papadopoulos, K. P.; Lalani, A. S.; Baselga, J. |
| Abstract Title: | Neratinib induces estrogen receptor function and sensitizes HER2-mutant breast cancer to anti-endocrine therapy |
| Meeting Title: | 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Journal Title: | European Journal of Cancer |
| Volume: | 69 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2016 Nov 29-Dec 2 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2016-12-01 |
| Start Page: | S125 |
| Language: | English |
| ACCESSION: | WOS:000390503500366 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(16)32971-9 |
| Notes: | Meeting Abstract: 378 -- 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics -- NOV 29-DEC 02, 2016 -- Munich, GERMANY -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
